Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 15, 2002BloodOpen Access

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

View Full Paper
Ask AI
Bookmark
Share

Authors

RMRobert J. McKallipCLCatherine LombardMFMichael T. Fisher

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

McKallip et al. (2002) studied this question.

synapsesocial.com/papers/6a809cbf1024bacc9692bad8https://doi.org/10.1182/blood-2002-01-0098
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1How to develop a business case for quality2006 · 42 citations
  2. 2Evidence for the Participation of Interleukin-2 (IL-2) and IL-4 in the Regulation of Autonomous Growth and Tumorigenesis of Transformed Cells of Lymphoid Origin1997 · 16 citations